ripekg:evaluation/RIPEAF7E1928294A86E83 |
prov:used |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
dcterms:creator |
ripekg:author/pubpeer-RIPEAF7E1928294A86E83-3Dysdera arabisenen |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
dcterms:date |
August 2025 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
http://purl.org/spar/fabio/hasURL |
https://pubpeer.com/publications/653EF82D99E63E11A490F9BB95D7C9 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
http://purl.org/spar/fabio/Comment |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
rdfs:Resource |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
owl:Thing |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
ripe:PeerCommentPeer comment |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
rdf:type |
tido:Evidence |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
prov:wasAttributedTo |
ripekg:source/pubpeerPubPeer |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF7E1928294A86E83 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF7E1928294A86E83 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
https://schema.org/text |
[Image: Chart or data image from the publication]
In all 3 studies, the SE values for “adjusted change” of FPG (mg/dL) are 1.7 for both control and treated groups. Similarly, the SE values for HDL adjusted change are 1.3 in all 6 groups (across 3 studies). In each of the 3 studies, control and treated groups have different means, but identical SE values across all measures. (expression of concern) |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
ripe:concerns |
ripekg:work/10.1016%2Fj.jacl.2015.12.017A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-human-1-2 |
ripekg:peer-comment/RIPEAF7E1928294A86E83-3 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-inspectai-1-2 |